These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27244688)

  • 1. Impact of the increased adoption of prenatal cfDNA screening on non-profit patient advocacy organizations in the United States.
    Meredith S; Kaposy C; Miller VJ; Allyse M; Chandrasekharan S; Michie M;
    Prenat Diagn; 2016 Aug; 36(8):714-9. PubMed ID: 27244688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Counselors' Perspectives About Cell-Free DNA: Experiences, Challenges, and Expectations for Obstetricians.
    Agatisa PK; Mercer MB; Coleridge M; Farrell RM
    J Genet Couns; 2018 Dec; 27(6):1374-1385. PubMed ID: 29951719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing Group Prenatal Counseling for Expanded Noninvasive Screening Options.
    Gammon BL; Otto L; Wick M; Borowski K; Allyse M
    J Genet Couns; 2018 Aug; 27(4):894-901. PubMed ID: 29247311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chorionic villus sampling in the cell-free DNA aneuploidy screening era: careful selection criteria can maximise the clinical utility of screening and invasive testing.
    Kane SC; Reidy KL; Norris F; Nisbet DL; Kornman LH; Palma-Dias R
    Prenat Diagn; 2017 Apr; 37(4):399-408. PubMed ID: 28207933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities.
    Norton ME; Baer RJ; Wapner RJ; Kuppermann M; Jelliffe-Pawlowski LL; Currier RJ
    Am J Obstet Gynecol; 2016 Jun; 214(6):727.e1-6. PubMed ID: 26709085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Offering Prenatal Screening in the Age of Genomic Medicine: A Practical Guide.
    Allyse M; Aypar U; Bonhomme N; Darilek S; Dougherty M; Farrell R; Grody W; Highsmith WE; Michie M; Nunes M; Otto L; Pabst R; Palomaki G; Runke C; Sharp RR; Skotko B; Stoll K; Wick M
    J Womens Health (Larchmt); 2017 Jul; 26(7):755-761. PubMed ID: 28388340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal cfDNA screening results indicative of maternal neoplasm: survey of current practice and management needs.
    Giles ME; Murphy L; Krstić N; Sullivan C; Hashmi SS; Stevens B
    Prenat Diagn; 2017 Feb; 37(2):126-132. PubMed ID: 27878832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Where have all the trisomies gone?
    Palomaki GE; Lambert-Messerlian GM; Haddow JE
    Am J Obstet Gynecol; 2016 Nov; 215(5):583-587.e1. PubMed ID: 27793310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free DNA analysis for noninvasive examination of trisomy.
    Norton ME; Jacobsson B; Swamy GK; Laurent LC; Ranzini AC; Brar H; Tomlinson MW; Pereira L; Spitz JL; Hollemon D; Cuckle H; Musci TJ; Wapner RJ
    N Engl J Med; 2015 Apr; 372(17):1589-97. PubMed ID: 25830321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.
    Sarno L; Revello R; Hanson E; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):705-11. PubMed ID: 26970114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-Free DNA Screening for Aneuploidy and Microdeletion Syndromes.
    Shaffer BL; Norton ME
    Obstet Gynecol Clin North Am; 2018 Mar; 45(1):13-26. PubMed ID: 29428281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-free DNA screening for fetal aneuploidy as a clinical service.
    Cuckle H; Benn P; Pergament E
    Clin Biochem; 2015 Oct; 48(15):932-41. PubMed ID: 25732593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UK NHS pilot study on cell-free DNA testing in screening for fetal trisomies: factors affecting uptake.
    Gil MM; Giunta G; Macalli EA; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):67-73. PubMed ID: 25302655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell free DNA testing-interpretation of results using an online calculator.
    Grace MR; Hardisty E; Green NS; Davidson E; Stuebe AM; Vora NL
    Am J Obstet Gynecol; 2015 Jul; 213(1):30.e1-30.e4. PubMed ID: 25957020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of the first trimester ultrasound in the era of cell free DNA screening.
    Rao RR; Valderramos SG; Silverman NS; Han CS; Platt LD
    Prenat Diagn; 2016 Dec; 36(13):1192-1198. PubMed ID: 27813114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for Implementing Cell-Free DNA Testing.
    Cuckle H
    Clin Lab Med; 2016 Jun; 36(2):213-26. PubMed ID: 27235907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cell-free fetal DNA analysis in maternal plasma as a screening test for trisomy 21 in twin pregnancies].
    Le Conte G; Letourneau A; Jani J; Kleinfinger P; Lohmann L; Costa JM; Benachi A
    Gynecol Obstet Fertil Senol; 2018; 46(7-8):580-586. PubMed ID: 29929941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttest risk calculation following positive noninvasive prenatal screening using cell-free DNA in maternal plasma.
    Benn P
    Am J Obstet Gynecol; 2016 Jun; 214(6):676.e1-7. PubMed ID: 26772793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.